Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 971

1.

Gains of EPOR and ERG genes in adult erythroleukaemia.

Adélaïde J, Cervera N, Guille A, Murati A, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D, Gelsi-Boyer V.

Br J Haematol. 2020 Mar 29. doi: 10.1111/bjh.16586. [Epub ahead of print] No abstract available.

PMID:
32227335
2.

The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtype.

Bertucci F, Finetti P, Goncalves A, Birnbaum D.

NPJ Breast Cancer. 2020 Mar 6;6:8. doi: 10.1038/s41523-020-0151-5. eCollection 2020.

3.

Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC.

Doghman-Bouguerra M, Finetti P, Durand N, Parise IZS, Sbiera S, Cantini G, Canu L, Hescot S, Figueiredo MMO, Komechen H, Sbiera I, Nesi G, Paci A, Al Ghuzlan A, Birnbaum D, Baudin E, Luconi M, Fassnacht M, Figueiredo BC, Bertucci F, Lalli E.

Cancers (Basel). 2020 Mar 14;12(3). pii: E689. doi: 10.3390/cancers12030689.

4.

Adolescents and young adults with classical Hodgkin lymphoma in North Tunisia: Insights from an adult single-institutional study.

Zawati I, Adouni O, Finetti P, Manai M, Manai M, Gamoudi A, Birnbaum D, Bertucci F, Mezlini A.

Cancer Radiother. 2020 Mar 11. pii: S1278-3218(20)30049-4. doi: 10.1016/j.canrad.2020.01.004. [Epub ahead of print]

PMID:
32171674
5.

EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant-related lymphomas.

Mescam L, Camus V, Schiano JM, Adélaïde J, Picquenot JM, Guille A, Bannier M, Ruminy P, Viailly PJ, Jardin F, Bouabdallah R, Brenot Rossi I, Bohers E, Robe C, Laurent C, Birnbaum D, Wotherspoon A, Gaulard P, Xerri L.

Blood. 2020 Feb 28. pii: blood.2019003408. doi: 10.1182/blood.2019003408. [Epub ahead of print] No abstract available.

PMID:
32110798
6.

Evaluation of the National Healthcare Safety Network standardized infection ratio risk adjustment for healthcare-facility-onset Clostridioides difficile infection in intensive care, oncology, and hematopoietic cell transplant units in general acute-care hospitals.

Polage CR, Quan KA, Madey K, Myers FE, Wightman DA, Krishna S, Grein JD, Gibbs L, Yokoe D, Mabalot SC, Chinn R, Hallmark A, Rubin Z, Fontenot M, Cohen S, Birnbaum D, Huang SS, Torriani FJ.

Infect Control Hosp Epidemiol. 2020 Feb 13:1-7. doi: 10.1017/ice.2020.4. [Epub ahead of print]

PMID:
32052726
7.

Prognostic impact of tumour-infiltrating lymphocytes and cancer-associated fibroblasts in patients with pancreatic adenocarcinoma of the body and tail undergoing resection.

Delayre T, Guilbaud T, Resseguier N, Mamessier E, Rubis M, Moutardier V, Fara R, Berdah SV, Garcia S, Birnbaum DJ.

Br J Surg. 2020 Jan 21. doi: 10.1002/bjs.11434. [Epub ahead of print]

PMID:
31960955
8.

Overexpression of Annexin A1 Is an Independent Predictor of Longer Overall Survival in Epithelial Ovarian Cancer.

Manai M, Doghri R, Finetti P, Mrad K, Bouabsa R, Manai M, Birnbaum D, Bertucci F, Charfi L, Driss M.

In Vivo. 2020 Jan-Feb;34(1):177-184. doi: 10.21873/invivo.11759.

9.

NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.

Bertucci F, Rypens C, Finetti P, Guille A, Adélaïde J, Monneur A, Carbuccia N, Garnier S, Dirix P, Gonçalves A, Vermeulen P, Debeb BG, Wang X, Dirix L, Ueno NT, Viens P, Cristofanilli M, Chaffanet M, Birnbaum D, Van Laere S.

Mol Oncol. 2020 Mar;14(3):504-519. doi: 10.1002/1878-0261.12621. Epub 2020 Feb 5.

10.

Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.

Laurent C, Nicolae A, Laurent C, Le Bras F, Haioun C, Fataccioli V, Amara N, Adélaïde J, Guille A, Schiano JM, Tesson B, Traverse-Glehen A, Chenard MP, Mescam L, Moreau A, Chassagne-Clement C, Somja J, Escudié F, André M, Martin N, Lacroix L, Lemonnier F, Hamy AS, Reyal F, Bannier M, Oberic L, Prade N, Frénois FX, Beldi-Ferchiou A, Delfau-Larue MH, Bouabdallah R, Birnbaum D, Brousset P, Xerri L, Gaulard P.

Blood. 2020 Jan 30;135(5):360-370. doi: 10.1182/blood.2019001904.

11.

MARCKS protein overexpression is associated with poor prognosis in male breast cancer.

Manai M, Abdeljaoued S, Goucha A, Adouni O, Bettaieb I, Bouzaien H, Rahal K, Birnbaum D, Bertucci F, Gamoudi A.

Cancer Biomark. 2019;26(4):513-522. doi: 10.3233/CBM-190637.

PMID:
31771045
12.

PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma.

Billon E, Finetti P, Bertucci A, Niccoli P, Birnbaum D, Mamessier E, Bertucci F.

Oncoimmunology. 2019 Aug 28;8(11):e1655362. doi: 10.1080/2162402X.2019.1655362. eCollection 2019.

PMID:
31646101
13.

Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation.

Garciaz S, N'guyen Dasi L, Finetti P, Chevalier C, Vernerey J, Poplineau M, Platet N, Audebert S, Pophillat M, Camoin L, Bertucci F, Calmels B, Récher C, Birnbaum D, Chabannon C, Vey N, Duprez E.

Clin Epigenetics. 2019 Oct 12;11(1):141. doi: 10.1186/s13148-019-0738-6.

14.

Acute erythroid leukemias have a distinct molecular hierarchy from non-erythroid acute myeloid leukemias.

Cervera N, Lhoumeau AC, Adélaïde J, Guille A, Murati A, Mozziconacci MJ, Vey N, Birnbaum D, Gelsi-Boyer V.

Haematologica. 2019 Oct 10. pii: haematol.2019.231142. doi: 10.3324/haematol.2019.231142. [Epub ahead of print]

15.

Machine-Learning Classification Suggests That Many Alphaproteobacterial Prophages May Instead Be Gene Transfer Agents.

Kogay R, Neely TB, Birnbaum DP, Hankel CR, Shakya M, Zhaxybayeva O.

Genome Biol Evol. 2019 Oct 1;11(10):2941-2953. doi: 10.1093/gbe/evz206.

16.

A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells.

Arfaoui A, Rioualen C, Azzoni V, Pinna G, Finetti P, Wicinski J, Josselin E, Macario M, Castellano R, Léonard-Stumpf C, Bal A, Gros A, Lossy S, Kharrat M, Collette Y, Bertucci F, Birnbaum D, Douik H, Bidaut G, Charafe-Jauffret E, Ginestier C.

EMBO Mol Med. 2019 Oct;11(10):e9930. doi: 10.15252/emmm.201809930. Epub 2019 Sep 2.

17.

A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers.

de Nonneville A, Finetti P, Adelaide J, Lambaudie É, Viens P, Gonçalves A, Birnbaum D, Mamessier E, Bertucci F.

Cancers (Basel). 2019 Aug 13;11(8). pii: E1158. doi: 10.3390/cancers11081158.

18.

Learning Curve in Laparoscopic Liver Resection, Educational Value of Simulation and Training Programmes: A Systematic Review.

Guilbaud T, Birnbaum DJ, Berdah S, Farges O, Beyer Berjot L.

World J Surg. 2019 Nov;43(11):2710-2719. doi: 10.1007/s00268-019-05111-x. Review.

PMID:
31384997
19.

Targeted molecular characterization shows differences between primary and secondary myelofibrosis.

Courtier F, Garnier S, Carbuccia N, Guille A, Adélaide J, Chaffanet M, Hirsch P, Paz DL, Slama B, Vey N, Ugo V, Delhommeau F, Rey J, Birnbaum D, Murati A.

Genes Chromosomes Cancer. 2019 Jul 24. doi: 10.1002/gcc.22789. [Epub ahead of print]

PMID:
31340059
20.

Author Correction: Genomic characterization of metastatic breast cancers.

Bertucci F, Ng CKY, Patsouris A, Droin N, Piscuoglio S, Carbuccia N, Soria JC, Dien AT, Adnani Y, Kamal M, Garnier S, Meurice G, Jimenez M, Dogan S, Verret B, Chaffanet M, Bachelot T, Campone M, Lefeuvre C, Bonnefoi H, Dalenc F, Jacquet A, De Filippo MR, Babbar N, Birnbaum D, Filleron T, Le Tourneau C, André F.

Nature. 2019 Aug;572(7767):E7. doi: 10.1038/s41586-019-1380-3.

PMID:
31308536
21.

Sensitive and easy screening for circulating tumor cells by flow cytometry.

Lopresti A, Malergue F, Bertucci F, Liberatoscioli ML, Garnier S, DaCosta Q, Finetti P, Gilabert M, Raoul JL, Birnbaum D, Acquaviva C, Mamessier E.

JCI Insight. 2019 Jun 13;5. pii: 128180. doi: 10.1172/jci.insight.128180.

22.

Assessment of a Vacuum-Based Intra-Colonic Diverting Device: A Preclinical Study.

Khosrovani C, Birnbaum DJ, Berdah S, Beyer-Berjot L.

Surg Innov. 2019 Oct;26(5):581-587. doi: 10.1177/1553350619851670. Epub 2019 Jun 11.

PMID:
31185816
23.

Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease.

Mari R, Mamessier E, Lambaudie E, Provansal M, Birnbaum D, Bertucci F, Sabatier R.

Cancers (Basel). 2019 Jun 4;11(6). pii: E774. doi: 10.3390/cancers11060774. Review.

24.

Glucagonoma with Paraneoplasic Dermatitis: Diagnosis and Management.

Guilbaud T, Berbis P, Birnbaum DJ.

J Gastrointest Surg. 2020 Mar;24(3):701-703. doi: 10.1007/s11605-019-04267-0. Epub 2019 May 31. No abstract available.

PMID:
31152349
25.

PARP1 expression in soft tissue sarcomas is a poor-prognosis factor and a new potential therapeutic target.

Bertucci F, Finetti P, Monneur A, Perrot D, Chevreau C, Le Cesne A, Blay JY, Mir O, Birnbaum D.

Mol Oncol. 2019 Jul;13(7):1577-1588. doi: 10.1002/1878-0261.12522. Epub 2019 Jun 7.

26.

Genomic characterization of metastatic breast cancers.

Bertucci F, Ng CKY, Patsouris A, Droin N, Piscuoglio S, Carbuccia N, Soria JC, Dien AT, Adnani Y, Kamal M, Garnier S, Meurice G, Jimenez M, Dogan S, Verret B, Chaffanet M, Bachelot T, Campone M, Lefeuvre C, Bonnefoi H, Dalenc F, Jacquet A, De Filippo MR, Babbar N, Birnbaum D, Filleron T, Le Tourneau C, André F.

Nature. 2019 May;569(7757):560-564. doi: 10.1038/s41586-019-1056-z. Epub 2019 May 22. Erratum in: Nature. 2019 Aug;572(7767):E7.

PMID:
31118521
27.

A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases.

Tyran M, Carbuccia N, Garnier S, Guille A, Adelaïde J, Finetti P, Toulzian J, Viens P, Tallet A, Goncalves A, Metellus P, Birnbaum D, Chaffanet M, Bertucci F.

Cancers (Basel). 2019 May 13;11(5). pii: E665. doi: 10.3390/cancers11050665.

28.

XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma.

Birnbaum DJ, Finetti P, Birnbaum D, Mamessier E, Bertucci F.

J Clin Med. 2019 Apr 30;8(5). pii: E596. doi: 10.3390/jcm8050596.

29.

Congo Red Fluorescence for Rapid In Situ Characterization of Synthetic Curli Systems.

Kan A, Birnbaum DP, Praveschotinunt P, Joshi NS.

Appl Environ Microbiol. 2019 Jun 17;85(13). pii: e00434-19. doi: 10.1128/AEM.00434-19. Print 2019 Jul 1.

30.

Reply to: The cystic duct syndrome is still actual.

Guilbaud T, Birnbaum DJ.

Surgery. 2019 Dec;166(6):1198-1199. doi: 10.1016/j.surg.2019.03.001. Epub 2019 Apr 9. No abstract available.

PMID:
30979426
31.

ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer.

Daulat AM, Finetti P, Revinski D, Silveira Wagner M, Camoin L, Audebert S, Birnbaum D, Kodjabachian L, Borg JP, Bertucci F.

Br J Cancer. 2019 Apr;120(9):931-940. doi: 10.1038/s41416-019-0448-z. Epub 2019 Apr 11.

32.

Head and Body/Tail Pancreatic Carcinomas Are Not the Same Tumors.

Birnbaum DJ, Bertucci F, Finetti P, Birnbaum D, Mamessier E.

Cancers (Basel). 2019 Apr 8;11(4). pii: E497. doi: 10.3390/cancers11040497.

33.

ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2.

Lévêque R, Corbet C, Aubert L, Guilbert M, Lagadec C, Adriaenssens E, Duval J, Finetti P, Birnbaum D, Magné N, Chopin V, Bertucci F, Le Bourhis X, Toillon RA.

Cancer Lett. 2019 May 1;449:196-206. doi: 10.1016/j.canlet.2019.02.019. Epub 2019 Feb 13.

PMID:
30771434
34.

Inflammatory breast cancer in 210 patients: A retrospective study on epidemiological, anatomo-clinical features and therapeutic results.

Manai M, Finetti P, Mejri N, Athimni S, Birnbaum D, Bertucci F, Rahal K, Gamoudi A, Chaffanet M, Manai M, Boussen H.

Mol Clin Oncol. 2019 Feb;10(2):223-230. doi: 10.3892/mco.2018.1773. Epub 2018 Nov 26.

35.

Mutation patterns in essential thrombocythemia, polycythemia vera and secondary myelofibrosis.

Wanquet A, Courtier F, Guille A, Carbuccia N, Garnier S, Adélaide J, Gelsi-Boyer V, Mozziconacci MJ, Rey J, Vey N, Birnbaum D, Murati A.

Leuk Lymphoma. 2019 May;60(5):1289-1293. doi: 10.1080/10428194.2018.1522437. Epub 2019 Jan 2. No abstract available.

PMID:
30601073
36.

Pathological grade-independent prediction of chemosensitivity by CINSARC should rehabilitate adjuvant chemotherapy in soft tissue sarcomas of any grade.

Bertucci F, Finetti P, Monneur A, Birnbaum D.

Ann Oncol. 2019 Feb 1;30(2):342-343. doi: 10.1093/annonc/mdy528. No abstract available.

37.

Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolution.

Xerri L, Adélaïde J, Avenin M, Guille A, Taix S, Bonnet N, Carbuccia N, Garnier S, Mescam L, Murati A, Chaffanet M, Coso D, Bouabdallah R, Bertucci F, Birnbaum D.

Histopathology. 2019 Mar;74(4):654-662. doi: 10.1111/his.13783. Epub 2019 Jan 31.

PMID:
30393995
38.

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer.

Bertucci F, Finetti P, Simeone I, Hendrickx W, Wang E, Marincola FM, Viens P, Mamessier E, Ceccarelli M, Birnbaum D, Bedognetti D.

Br J Cancer. 2018 Nov;119(11):1383-1391. doi: 10.1038/s41416-018-0309-1. Epub 2018 Oct 24.

39.

Thomas Mann and Neurology.

Caputi N, Birnbaum D, Boller F.

Front Neurol Neurosci. 2018;43:76-84. doi: 10.1159/000490406. Epub 2018 Oct 18.

PMID:
30336458
40.

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer.

Guerin M, Gonçalves A, Toiron Y, Baudelet E, Pophillat M, Granjeaud S, Fourquet P, Jacot W, Tarpin C, Sabatier R, Agavnian E, Finetti P, Adelaide J, Birnbaum D, Ginestier C, Charafe-Jauffret E, Viens P, Bertucci F, Borg JP, Camoin L.

Oncotarget. 2018 Sep 18;9(73):33762-33777. doi: 10.18632/oncotarget.26031. eCollection 2018 Sep 18.

41.

Preoperative Biliary Stenting and Major Morbidity After Pancreatoduodenectomy: Does Elapsed Time Matter?: The FRAGERITA Study Group.

Sandini M, Honselmann KC, Birnbaum DJ, Gavazzi F, Chirica M, Wellner U, Guilbaud T, Bolm L, Angrisani M, Moutardier V, Cereda M, Girard É, Montorsi M, Keck T, Zerbi A, Gianotti L.

Ann Surg. 2018 Nov;268(5):808-814. doi: 10.1097/SLA.0000000000002838.

PMID:
30303874
42.

Circulating tumour DNA as an early marker of recurrence and treatment efficacy in ovarian carcinoma, the CIDOC study.

Sabatier R, Pomel C, Colombo PE, Narducci F, Garnier S, Carbuccia N, Guille A, Birnbaum D, Zemmour C, Lambaudie E.

Ann Oncol. 2018 Sep;29 Suppl 6:vi3. doi: 10.1093/annonc/mdy316.007. Epub 2020 Jan 7. No abstract available.

43.

A major response to carboplatin in a metastatic triple-negative breast cancer patient with somatic mutation of BRCA1 and RAD51B: When chemotherapy meets precision medicine.

Seguin L, Chaffanet M, Sabatier R, Jose A, Garnier S, Carbuccia N, Guille A, Birnbaum D, Bertucci F, Goncalves A.

Ann Oncol. 2018 Sep;29 Suppl 6:vi29. doi: 10.1093/annonc/mdy314.030. Epub 2020 Jan 7. No abstract available.

44.

RETROSPHER. ERBB2 amplification detection in the plasma at diagnosis for early high-risk HER2-positive breast cancer.

Sabatier R, Garnier S, Carbuccia N, Guille A, Tarpin C, Goncalves A, Birnbaum D.

Ann Oncol. 2018 Sep;29 Suppl 6:vi1. doi: 10.1093/annonc/mdy316.001. Epub 2020 Jan 7. No abstract available.

45.

Mutation of FOP/FGFR1OP in mice recapitulates human short rib-polydactyly ciliopathy.

Cabaud O, Roubin R, Comte A, Bascunana V, Sergé A, Sedjaï F, Birnbaum D, Rosnet O, Acquaviva C.

Hum Mol Genet. 2018 Oct 1;27(19):3377-3391. doi: 10.1093/hmg/ddy246.

PMID:
29982567
46.

CMTM6 stabilizes PD-L1 expression and refines its prognostic value in tumors.

Mamessier E, Birnbaum DJ, Finetti P, Birnbaum D, Bertucci F.

Ann Transl Med. 2018 Feb;6(3):54. doi: 10.21037/atm.2017.11.26. No abstract available.

47.

Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer.

Birnbaum DJ, Bertucci F, Finetti P, Birnbaum D, Mamessier E.

Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):248-255. doi: 10.1016/j.bbcan.2018.02.001. Epub 2018 Feb 28. Review.

PMID:
29499330
48.

C-Reactive Protein on Postoperative Day 1 Is a Reliable Predictor of Pancreas-Specific Complications After Pancreaticoduodenectomy.

Guilbaud T, Birnbaum DJ, Lemoine C, Chirica M, Risse O, Berdah S, Girard E, Moutardier V.

J Gastrointest Surg. 2018 May;22(5):818-830. doi: 10.1007/s11605-017-3658-9. Epub 2018 Jan 4.

PMID:
29327310
49.

"Wnt/β-Catenin in GIST"-Letter.

Bertucci F, Finetti P, De Nonneville A, Birnbaum D.

Mol Cancer Ther. 2018 Jan;17(1):327-328. doi: 10.1158/1535-7163.MCT-17-0948.

50.

Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value.

Doghri R, Manai M, Finetti P, Driss M, Agavnian E, Lopez M, Elghardallou M, Charafe-Jauffret E, Manai M, Chaffanet M, Birnbaum D, Mrad K, Bertucci F.

Int J Mol Sci. 2017 Dec 23;19(1). pii: E41. doi: 10.3390/ijms19010041.

Supplemental Content

Loading ...
Support Center